Important new study by Wibmer et al (https://t.co/q6150ahSCz) of neutralization by convalescent sera on wildtype vs 501Y.V2 variant viruses circulating in South Africa. It shows that mutations present in 501Y.V2 result in reduced neutralization capacity. 1/10
John Bartlett just died -- a true visionary and the classic "Renaissance" person in clinical ID. Such a nice guy, too! His IDSA/IDWeek literature summaries (among other things) were amazing. We'll miss him! @IDSAInfohttps://t.co/VYRjln6qDC
Day#1 post-vaccine 2 - So far so good. Mild arm pain and muscle soreness. Like I did a shoulder workout at the gym. Weirdly my non- vaccinated shoulder hurts more then the vaccinated one....
#COVID19Vaccines remain safe https://t.co/RRsc5UM4Fe
Our Administration will lead with science and scientists — with a CDC and NIH that are free from political influence, a Surgeon General who is independent and speaks directly to the people, and an FDA whose decisions are based on science and science alone.
At this point, the countries with most genomic data to analyze spread of the variant virus belonging to https://t.co/ImaHU6Jxdv B.1.1.7 lineage or @nextstrain clade 20I/501Y.V1 are the UK, Denmark and the USA. Here I compare growth rates of B.1.17 across these countries. 1/13